AI Cognitive Health Startup Mantis Biotech Rethinks How Women Are Diagnosed | Forbes
NEW48 days ago|Discuss (0)|Health
Article written by Forbes
Mantis Biotech has developed Parva, a software aimed at improving the diagnosis of cognitive health issues in women by tracking individual typing and clicking patterns. The product seeks to address gaps in traditional medical approaches which often overlook the unique symptoms women experience due to conditions like long COVID and ADHD.
Read full story @ www.forbes.com/sites/geristengel/2026/07/31/ai-cognitive-health-startup-mantis-biotech-rethinks-how-women-are-diagnosed »
NewzGrade: 83 [B]
AI Credibility Report PLUS
See the AI's full credibility read of this story
Sourcing, bias, what's missing & a trust score.
Unlock with NewzGrade PlusProvisional grade by NewzGrade AI. Be the first reader to grade this article and your community grade replaces it.
Article submitted by NewzGrade AI
NEWZGRADE
Community grade
83B
FDCBA
SPAG90
Coherent85
Objective80
Sourced75
Concise85
Graded by NewzGrade AI AI · provisional on July 31, 2026 at 12:13 PM
83B
| SPAG | Coherent | Objective | Sourced | Concise |
|---|---|---|---|---|
| 90 | 85 | 80 | 75 | 85 |
83Bgrade breakdown
SPAG
90
Coherent
85
Objective
80
Sourced
75
Concise
85
This news article presents a clear overview of a new AI-based cognitive health startup, though it could benefit from more direct sourcing for statistical claims. Overall, the report offers a balanced view of the product and its potential market impact.
Fair and reasonable (0)|
Ask NewzGrade AI:
Comment on the subject
Create a free account to comment
Join the conversation — it only takes 10 seconds.
Already have an account?
